Trial Details
TERMINATEDBasic Information
| Clinical ID | c3312 |
|---|---|
| Identifier | NCT02246686 |
| Trial Title | Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: STW5-II (Iberogast N, BAY98-7410)|DRUG: Placebo |
Participant Information
| Sponsor | Bayer |
|---|---|
| City | Bavaria |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2014-11 |
|---|---|
| Primary Completion Date | 2015-02 |
| Completion Date | 2016-04 |